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, Kato and colleagues included a discussion on the negative effect of the disease on patients' quality of life. In Figure 7 , the authors compared the healthrelated quality of life (HRQOL) of paediatric and adult patients with SCD to that of patients with other chronic diseases, including cystic fibrosis, cancer and asthma, and patients on dialysis.
HRQOL was measured in adults using the 36-Item Short Form Health Survey (SF-36) 2 . In this figure, SCD ranked at an intermediate place for HRQOL compared with other diseases, and patients on dialysis had the lowest SF-36 score of ~45 out of 100. After analysing Figure 7 , we found that the conclusions that might be drawn from it have limitations and bias.
First, as stated in the figure legend, HRQOL in Figure 7 only includes the physical functioning score from the SF-36 (REF.
).
However, this score is only one of the eight subscales of the SF-36, along with physical role functioning, emotional role functioning, bodily pain, vitality, general health, mental health and social function 2 . It might have been more-appropriate to compare HRQOL in chronic diseases using complete SF-36 measures. Figure 7 was based in part on data from a 2005 paper by McClish and colleagues, who compared the SF-36 scores of patients living with SCD with data from other When designing schematic visualizations, we should bear in mind that these items are easy to use by media or patients' associations 6 . Thus, we should be careful to integrate only comprehensive and good-quality evidence, especially on matters such as HRQOL, which are of great concern for patients.
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